Literature DB >> 8173020

Rapid eye movement sleep disturbance in posttraumatic stress disorder.

R J Ross1, W A Ball, D F Dinges, N B Kribbs, A R Morrison, S M Silver, F D Mulvaney.   

Abstract

The subjective sleep disturbance in posttraumatic stress disorder (PTSD), including the repetitive, stereotypical anxiety dream, suggests dysfunctional rapid eye movement (REM) sleep mechanisms. The polysomnograms of a group of physically healthy combat veterans with current PTSD were compared with those of an age-appropriate normal control group. Tonic and phasic REM sleep measures in the PTSD subjects were elevated on the second night of recorded sleep. Increased phasic REM sleep activity persisted in the PTSD group on the subsequent night. During the study, an anxiety dream occurred in a PTSD subject in REM sleep. The results are consistent with the view that a dysregulation of the REM sleep control system, particularly phasic event generation, may be involved in the pathogenesis of PTSD. The finding of a specific disturbance of sleep unique to PTSD may have significant implications for the design of effective treatments for PTSD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8173020     DOI: 10.1016/0006-3223(94)91152-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  51 in total

Review 1.  Stress-induced changes in sleep in rodents: models and mechanisms.

Authors:  Aaron C Pawlyk; Adrian R Morrison; Richard J Ross; Francis X Brennan
Journal:  Neurosci Biobehav Rev       Date:  2007-06-29       Impact factor: 8.989

2.  Evening-type military veterans report worse lifetime posttraumatic stress symptoms and greater brainstem activity across wakefulness and REM sleep.

Authors:  Brant P Hasler; Salvatore P Insana; Jeffrey A James; Anne Germain
Journal:  Biol Psychol       Date:  2013-07-02       Impact factor: 3.251

3.  Effects of Optogenetic inhibition of BLA on Sleep Brief Optogenetic Inhibition of the Basolateral Amygdala in Mice Alters Effects of Stressful Experiences on Rapid Eye Movement Sleep.

Authors:  Mayumi Machida; Laurie L Wellman; Mairen E Fitzpatrick Bs; Olga Hallum Bs; Amy M Sutton Bs; György Lonart; Larry D Sanford
Journal:  Sleep       Date:  2017-04-01       Impact factor: 5.849

Review 4.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 5.  Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

Authors:  Michael J Maher; Simon A Rego; Gregory M Asnis
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Long-term effect of cued fear conditioning on REM sleep microarchitecture in rats.

Authors:  Vibha Madan; Francis X Brennan; Graziella L Mann; Apryle A Horbal; Gregory A Dunn; Richard J Ross; Adrian R Morrison
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

Review 7.  Sleep disturbances as the hallmark of PTSD: where are we now?

Authors:  Anne Germain
Journal:  Am J Psychiatry       Date:  2013-04       Impact factor: 18.112

8.  The effect of continuous positive air pressure (CPAP) on nightmares in patients with posttraumatic stress disorder (PTSD) and obstructive sleep apnea (OSA).

Authors:  Sadeka Tamanna; Jefferson D Parker; Judith Lyons; M I Ullah
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

9.  Quantitative electroencephalography during rapid eye movement (REM) and non-REM sleep in combat-exposed veterans with and without post-traumatic stress disorder.

Authors:  Daniel J Cohen; Amy Begley; Jennie J Alman; David J Cashmere; Regina N Pietrone; Robert J Seres; Anne Germain
Journal:  J Sleep Res       Date:  2012-07-30       Impact factor: 3.981

10.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.